The Food and Drug Administration accepted additional data provided by AMAG Pharmaceuticals Inc. (Nasdaq: AMAG) for the company's anemia treatment ferumoxytol. The stock price leaped $14.94 to $33.31.
FDA Accepts AMAG Data
November 13, 2008 at 13:40 PM EST
